Ulcerative Colitis

IBD is thought to be caused by the influence of several factors, including genetic predisposition and environmental precipitants, on the gastrointestinal tract's response to the presence of normal and pathogenic bacteria in the gut.

The result is an immune response, causing inflammation of the intestinal wall.

About Cerimon Pharmaceuticals Cerimon Pharmaceuticals, Inc.

is a biopharmaceutical company dedicated to bringing innovative therapeutics to patients with substantial, unmet medical needs.

The Company is engaged in the development and commercialization of therapeutics in the areas of autoimmune disease, inflammation and pain.

In October 2005, Cerimon closed a Series A financing of $70M in a deal led by MPM, and including Nomura Phase4 Ventures and OrbiMed Advisors.

Cerimon is headquartered in South San Francisco, CA.

For more information on Cerimon, please visit the Company's Website at http://www.cerimon.com.

SOURCE Cerimon Pharmaceuticals, Inc.

Web Site: http://www.cerimon.com Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.Terms and conditions, including restrictions on redistribution, a...

Read more...